Similar articles for PMID: 32680924

Year	Number of Results
2020	20
2021	32
2022	2
2024	0

1

Oncology-Inspired Treatment Options for COVID-19.

Pillarsetty N, Carter LM, Lewis JS, Reiner T. Pillarsetty N, et al. J Nucl Med. 2020 Dec;61(12):1720-1723. doi: 10.2967/jnumed.120.249748. Epub 2020 Jul 17. J Nucl Med. 2020. PMID: 32680924 Free PMC article.

2

Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19.

Zhu T, Xiao Y, Meng X, Tang L, Li B, Zhao Z, Tan Q, Shan H, Liu L, Huang X. Zhu T, et al. J Nanobiotechnology. 2021 Nov 25;19(1):391. doi: 10.1186/s12951-021-01148-0. J Nanobiotechnology. 2021. PMID: 34823562 Free PMC article.

3

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.

Rattanapisit K, Shanmugaraj B, Manopwisedjaroen S, Purwono PB, Siriwattananon K, Khorattanakulchai N, Hanittinan O, Boonyayothin W, Thitithanyanont A, Smith DR, Phoolcharoen W. Rattanapisit K, et al. Sci Rep. 2020 Oct 19;10(1):17698. doi: 10.1038/s41598-020-74904-1. Sci Rep. 2020. PMID: 33077899 Free PMC article.

4

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody.

Nguyen H, Lan PD, Nissley DA, O'Brien EP, Li MS. Nguyen H, et al. J Phys Chem B. 2021 Jul 15;125(27):7368-7379. doi: 10.1021/acs.jpcb.1c03639. Epub 2021 Jul 6. J Phys Chem B. 2021. PMID: 34228472 Free PMC article.

5

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies.

Rattanapisit K, Bulaon CJI, Khorattanakulchai N, Shanmugaraj B, Wangkanont K, Phoolcharoen W. Rattanapisit K, et al. PLoS One. 2021 Aug 11;16(8):e0253574. doi: 10.1371/journal.pone.0253574. eCollection 2021. PLoS One. 2021. PMID: 34379620 Free PMC article.

6

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein.

Wrobel AG, Benton DJ, Hussain S, Harvey R, Martin SR, Roustan C, Rosenthal PB, Skehel JJ, Gamblin SJ. Wrobel AG, et al. Nat Commun. 2020 Oct 21;11(1):5337. doi: 10.1038/s41467-020-19146-5. Nat Commun. 2020. PMID: 33087721 Free PMC article.

7

Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.

Su W, Sia SF, Schmitz AJ, Bricker TL, Starr TN, Greaney AJ, Turner JS, Mohammed BM, Liu Z, Choy KT, Darling TL, Joshi A, Cheng KM, Wong AYL, Harastani HH, Nicholls JM, Whelan SPJ, Bloom JD, Yen HL, Ellebedy AH, Boon ACM. Su W, et al. mBio. 2021 Oct 26;12(5):e0239521. doi: 10.1128/mBio.02395-21. Epub 2021 Sep 14. mBio. 2021. PMID: 34517754 Free PMC article.

8

Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies.

Verkhivker GM, Di Paola L. Verkhivker GM, et al. J Phys Chem B. 2021 May 13;125(18):4596-4619. doi: 10.1021/acs.jpcb.1c00395. Epub 2021 Apr 30. J Phys Chem B. 2021. PMID: 33929853

9

The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.

Papageorgiou AC, Mohsin I. Papageorgiou AC, et al. Cells. 2020 Oct 22;9(11):2343. doi: 10.3390/cells9112343. Cells. 2020. PMID: 33105869 Free PMC article. Review.

10

Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector.

Rashed MZ, Kopechek JA, Priddy MC, Hamorsky KT, Palmer KE, Mittal N, Valdez J, Flynn J, Williams SJ. Rashed MZ, et al. Biosens Bioelectron. 2021 Jan 1;171:112709. doi: 10.1016/j.bios.2020.112709. Epub 2020 Oct 7. Biosens Bioelectron. 2021. PMID: 33075724 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year